Other
Other comprehensive income/(loss) before reclassifications
West Pharmaceutical Services Other comprehensive income/(loss) before reclassifications decreased by 117.3% to -$20.20M in Q1 2026 compared to the prior quarter. Year-over-year, this metric declined by 138.6%, from $52.30M to -$20.20M.
Analysis
StatementIncome Statement
SectionOther
CategoryRisk
SignalContext dependent
VolatilityVolatile
First reportedQ1 2021
Last reportedQ1 2026Apr 23, 2026
How to read this metric
Significant fluctuations indicate high exposure to market variables like interest rates or foreign exchange volatility.
Detailed definition
Measures changes in equity resulting from items not yet recognized in the income statement, such as unrealized gains or...
Peer comparison
Standard accounting metric for companies with significant hedging activities or defined benefit plans.
Metric ID:
other_oci_before_reclassifications_net_of_tax_attributab_bd801dHistorical Data
13 periods
| Q3 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q1 '25 | Q2 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | -$22.30M | -$23.60M | -$63.70M | -$76.00M | $14.20M | -$17.30M | -$42.80M | -$49.50M | -$25.00M | $80.30M | $52.30M | $117.00M | -$20.20M |
| QoQ Change | — | -5.8% | -169.9% | -19.3% | +118.7% | -221.8% | -147.4% | -15.7% | +49.5% | +421.2% | -34.9% | +123.7% | -117.3% |
| YoY Change | — | — | — | -240.8% | +160.2% | +72.8% | +43.7% | -448.6% | -44.5% | +287.6% | +205.7% | +568.0% | -138.6% |
Range-$76.00M – $117.00M
CAGR-3.2%
Avg YoY Growth+46.5%
Median YoY Growth+58.3%
Other comprehensive income/(loss) before reclassifications at Other Companies
Frequently Asked Questions
- What is West Pharmaceutical Services's other comprehensive income/(loss) before reclassifications?
- West Pharmaceutical Services (WST) reported other comprehensive income/(loss) before reclassifications of -$20.20M in Q1 2026.
- How has West Pharmaceutical Services's other comprehensive income/(loss) before reclassifications changed year-over-year?
- West Pharmaceutical Services's other comprehensive income/(loss) before reclassifications decreased by 138.6% year-over-year, from $52.30M to -$20.20M.
- What does other comprehensive income/(loss) before reclassifications mean?
- Unrealized gains or losses in equity before they are moved to the income statement.